Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blue dye could spare ovarian cancer patients from major surgery

NCT ID NCT07508306

Recruiting now Knowledge-focused Sponsor: Faculty of Medicine of Tunis Source: ClinicalTrials.gov ↗

First seen Apr 05, 2026 · Last updated May 23, 2026 · Updated 10 times

Summary

This study looks at whether a blue dye injected into the ovary can help find the first lymph node where cancer might spread in early ovarian cancer. Currently, standard surgery removes many lymph nodes, which can cause side effects. By checking only the dyed node, doctors hope to reduce risks. The study involves 30 women with early-stage ovarian cancer and aims to see if this method is accurate enough to replace the more extensive surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENTINEL LYMPH NODE BIOPSY (SLNB) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maternity and neonatology center of Tunis

    RECRUITING

    La Rabta, 1007, Tunisia

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

EARLY STAGE OVARIAN TUMORS SENTINEL LYMPH NODE BIOPSY (SLNB)